Brain Inflammation Emerges as Key Target for Alzheimer's Prevention and Treatment
New research reveals how targeting brain inflammation could unlock novel therapeutic approaches for Alzheimer's disease.
478 articles in this topic
New research reveals how targeting brain inflammation could unlock novel therapeutic approaches for Alzheimer's disease.
New study combines smartphone sensors, brain scans, and daily check-ins to predict suicide risk in vulnerable patients.
Brain-derived pTau217 blood test shows superior accuracy for detecting Alzheimer's pathology compared to existing tests.
New brain organoid study shows autophagy-boosting compounds can clear harmful tau proteins and rescue synapses in Alzheimer's disease models.
Antibody therapies show promise for preventing Alzheimer's in cognitively healthy people with disease biomarkers.
Recent breakthrough drugs targeting amyloid plaques slow cognitive decline, but combination therapies may unlock better outcomes.
New research reveals that inconsistent sleep timing and quality drive faster accumulation of toxic brain proteins linked to Alzheimer's disease.
Researchers modified astrocytes with chimeric antigen receptors to target amyloid plaques, showing promise for Alzheimer's treatment.
Higher cognitive reserve helps maintain mental sharpness despite age-related brain lesions that disrupt neural connections.
Large study finds genetic background doesn't explain mitochondrial damage in neurodegenerative disease, pointing to complex causes.
New research reveals a critical flaw in brain tumor diagnosis that could affect treatment decisions for aggressive cancers.
Editorial raises concerns about influential 2009 study on Cerebrolysin's effects on brain degeneration in Alzheimer's models.